New and emerging roles for mast cells in host defence

Current Opinion in Immunology

Volumn 19, Issue 1, 2007, Pages 31-38

  Dawicki, Wojciech ^a   Marshall, Jean S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; TOLL LIKE RECEPTOR;

BACTERIAL INFECTION; BACTERIUM; BLOOD VESSEL; CELL ACTIVITY; EFFECTOR CELL; GASTROINTESTINAL INFECTION; HOST RESISTANCE; HUMAN; HYPERTROPHY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPH NODE HYPERTROPHY; MAST CELL; MUCOSA; NONHUMAN; PARASITE; PARASITOSIS; PATHOGENESIS; RESPIRATORY TRACT INFECTION; REVIEW; SKIN INFECTION; VIRUS INFECTION;

ANIMALS; HUMANS; IMMUNITY, NATURAL; MAST CELLS;

EID: 33846086541     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.11.006     Document Type: Review

References (77)

1. Marshall J.S., and Jawdat D.M. Mast cells in innate immunity. J Allergy Clin Immunol 114 (2004) 21-27
2. Marshall J.S. Mast-cell responses to pathogens. Nat Rev Immunol 4 (2004) 787-799
3. Vliagoftis H., and Befus A.D. Mast cells at mucosal frontiers. Curr Mol Med 5 (2005) 573-589
4. Galli S.J., Nakae S., and Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005) 135-142
5. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., and Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23 (2005) 749-786
6. Echtenacher B., Mannel D.N., and Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 381 (1996) 75-77
7. Malaviya R., Ikeda T., Ross E., and Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α. Nature 381 (1996) 77-80
8. W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167 (2005) 835-848. This article describes the usefulness of the W-sh/W-sh mouse as a model for examining the role of mast cells in disease processes as well as providing important information on the success of mast cell reconstitutions in various tissues.
9. Tsai M., Grimbaldeston M.A., Yu M., Tam S.Y., and Galli S.J. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chem Immunol Allergy 87 (2005) 179-197
10. Saito H., Ebisawa M., Tachimoto H., Shichijo M., Fukagawa K., Matsumoto K., Iikura Y., Awaji T., Tsujimoto G., Yanagida M., et al. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 157 (1996) 343-350
11. Okayama Y., Kirshenbaum A.S., and Metcalfe D.D. Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ. J Immunol 164 (2000) 4332-4339
12. Kirshenbaum A.S., Akin C., Wu Y., Rottem M., Goff J.P., Beaven M.A., Rao V.K., and Metcalfe D.D. Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk Res 27 (2003) 677-682
13. Wei O.L., Hilliard A., Kalman D., and Sherman M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect Immun 73 (2005) 1978-1985
14. Velin D., Bachmann D., Bouzourene H., and Michetti P. Mast cells are critical mediators of vaccine-induced Helicobacter clearance in the mouse model. Gastroenterology 129 (2005) 142-155
15. Ebmeyer J., Furukawa M., Pak K., Ebmeyer U., Sudhoff H., Broide D., Ryan A.F., and Wasserman S. Role of mast cells in otitis media. J Allergy Clin Immunol 116 (2005) 1129-1135. This clinically relevant study uses a murine model to demonstrate the importance of mast cells in the prevention of otitis media.
16. Albiin N., Hellstrom S., Stenfors L.E., and Cerne A. Middle ear mucosa in rats and humans. Ann Otol Rhinol Laryngol Suppl 126 (1986) 2-15
17. Xu X., Zhang D., Lyubynska N., Wolters P.J., Killeen N.P., Baluk P., McDonald D.M., Hawgood S., and Caughey G.H. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med 173 (2006) 219-225
18. Jenkins C.E., Swiatoniowski A., Issekutz A.C., and Lin T.J. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism. J Biol Chem 279 (2004) 37201-37207
19. King C.A., Marshall J.S., Alshurafa H., and Anderson R. Release of vasoactive cytokines by antibody enhanced dengue virus infection of a human mast cell/basophil line. J Virol 74 (2000) 7146-7150
20. King C.A., Anderson R., and Marshall J.S. Dengue virus selectively induces human mast cell chemokine production. J Virol 76 (2002) 8408-8419
21. Brown MA, King CA, Marshall JS, Anderson RP: Fcγ receptor II mediates human mast cell dengue virus infection. J Leukoc Biol 2006, in press.
22. Bannert N., Farzan M., Friend D.S., Ochi H., Price K.S., Sodroski J., and Boyce J.A. Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro. J Virol 75 (2001) 10808-10814
23. Marone G., Florio G., Petraroli A., and de Paulis A. Dysregulation of the IgE/FcεRI network in HIV-1 infection. J Allergy Clin Immunol 107 (2001) 22-30
24. Li Y., Li L., Wadley R., Reddel S.W., Qi J.C., Archis C., Collins A., Clark E., Cooley M., Kouts S., et al. Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood 97 (2001) 3484-3490
25. Sundstrom J.B., Little D.M., Villinger F., Ellis J.E., and Ansari A.A. Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J Immunol 172 (2004) 4391-4401
26. Genovese A., Borgia G., Bouvet J.P., Detoraki A., de Paulis A., Piazza M., and Marone G. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. Int Arch Allergy Immunol 132 (2003) 336-345
27. Marone G., de Paulis A., Florio G., Petraroli A., Rossi F.W., and Triggiani M. Are mast cells MASTers in HIV-1 infection?. Int Arch Allergy Immunol 125 (2001) 89-95
28. Li E., Zhou P., Petrin Z., and Singer S.M. Mast cell-dependent control of Giardia lamblia infections in mice. Infect Immun 72 (2004) 6642-6649
29. McDermott J.R., Bartram R.E., Knight P.A., Miller H.R., Garrod D.R., and Grencis R.K. Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci USA 100 (2003) 7761-7766
30. Lawrence C.E., Paterson Y.Y., Wright S.H., Knight P.A., and Miller H.R. Mouse mast cell protease-1 is required for the enteropathy induced by gastrointestinal helminth infection in the mouse. Gastroenterology 127 (2004) 155-165
31. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., and Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 313 (2006) 526-530. In this article, the authors define a novel role for mast cell derived proteases in ameliorating the adverse effects of snake and bee venoms in vivo, determining a new aspect of mast cell function in host defence.
32. Sasaki Y., Yoshimoto T., Maruyama H., Tegoshi T., Ohta N., Arizono N., and Nakanishi K. IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J Exp Med 202 (2005) 607-616. This article defines a novel and unexpected role for IL-18 in the generation of effective mast cell-dependent immunity to Strongyloides infection. It suggests a wider interaction between IL-18 and mast cell function.
33. Onah D.N., and Nawa Y. Mucosal mast cell-derived chondroitin sulphate levels in and worm expulsion from FcRγ-knockout mice following oral challenge with Strongyloides venezuelensis. J Vet Sci 5 (2004) 221-226
34. + mucosal mast cell precursors from the bone marrow following infection with the intestinal nematode Trichinella spiralis. Blood 103 (2004) 2655-2660
35. Jolly S., Detilleux J., and Desmecht D. Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome. Vet Immunol Immunopathol 97 (2004) 125-136
36. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176 (2006) 4102-4112
37. Jawdat D.M., Albert E.J., Rowden G., Haidl I.D., and Marshall J.S. IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173 (2004) 5275-5282
38. Bryce P.J., Miller M.L., Miyajima I., Tsai M., Galli S.J., and Oettgen H.C. Immune sensitization in the skin is enhanced by antigen-independent effects of IgE. Immunity 20 (2004) 381-392
39. Jawdat D.M., Rowden G., and Marshall J.S. Mast cells have a pivotal role in TNF-independent lymph node hypertrophy and the mobilization of Langerhans cells in response to bacterial peptidoglycan. J Immunol 177 (2006) 1755-1762. This article demonstrates the importance of mast cells in mediating lymph node hypertrophy and Langerhans cell migration following peptidoglycan administration to the skin. Notably, mast cell dependent lymph node hypertrophy in this model was TNF-independent.
40. McLachlan J.B., Hart J.P., Pizzo S.V., Shelburne C.P., Staats H.F., Gunn M.D., and Abraham S.N. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4 (2003) 1199-1205
41. Demeure C.E., Brahimi K., Hacini F., Marchand F., Peronet R., Huerre M., St-Mezard P., Nicolas J.F., Brey P., Delespesse G., et al. Anopheles mosquito bites activate cutaneous mast cells leading to a local inflammatory response and lymph node hyperplasia. J Immunol 174 (2005) 3932-3940. This demonstrates the crucial role of mast cells in initiating local inflammatory responses as well as lymph node hypertrophy, including dendritic cell localization, in response to mosquito bites.
42. Depinay N., Hacini F., Beghdadi W., Peronet R., and Mecheri S. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 176 (2006) 4141-4146. This article demonstrates that mosquito bites in the skin induce local MIP-2 and IL-10 responses in the draining lymph node by way of a mast cell dependent mechanism. Decreased antigen-specific immune responses are observed following mosquito bites, suggesting a mechanism for decreased potential responses to infection with mosquito-borne pathogens.
43. Nakae S., Suto H., Iikura M., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176 (2006) 2238-2248
44. Nakae S., Suto H., Kakurai M., Sedgwick J.D., Tsai M., and Galli S.J. Mast cells enhance T cell activation: importance of mast cell-derived TNF. Proc Natl Acad Sci USA 102 (2005) 6467-6472. This article documents important effects of mast cells on T-cell activation, primarily, although not exclusively, as a result of mast cell TNF production. The mechanisms of these responses are further examined in [43].
45. Gombert M., Dieu-Nosjean M.C., Winterberg F., Bunemann E., Kubitza R.C., Da Cunha L., Haahtela A., Lehtimaki S., Muller A., Rieker J., et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 174 (2005) 5082-5091
46. + T-cell recruitment. Blood 106 (2005) 978-987
47. Mazzoni A., Young H.A., Spitzer J.H., Visintin A., and Segal D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 108 (2001) 1865-1873
48. Mazzoni A., and Segal D.M. Controlling the Toll road to dendritic cell polarization. J Leukoc Biol 75 (2004) 721-730
49. Lukacs N.W. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1 (2001) 108-116
50. McIlroy A., Caron G., Blanchard S., Fremaux I., Duluc D., Delneste Y., Chevailler A., and Jeannin P. Histamine and prostaglandin E up-regulate the production of Th2-attracting chemokines (CCL17 and CCL22) and down-regulate IFN-γ-induced CXCL10 production by immature human dendritic cells. Immunology 117 (2006) 507-516
51. Brightling C.E., Ammit A.J., Kaur D., Black J.L., Wardlaw A.J., Hughes J.M., and Bradding P. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med 171 (2005) 1103-1108. This intriguing study suggests an important role for CXCR3 ligands in the recruitment of mast cells to human airways smooth muscle. Such processes could potentially be important in the exacerbation of asthma symptoms associated with viral infection.
52. Weller C.L., Collington S.J., Brown J.K., Miller H.R., Al-Kashi A., Clark P., Jose P.J., Hartnell A., and Williams T.J. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J Exp Med 201 (2005) 1961-1971. This article demonstrates an important additional role for Leukotriene B4 frequently produced in response to bacterial infection and already implicated in the recruitment of neutrophils and T-cell subsets. Such Leukotriene B4 can serve as a potent chemoattractant for mast cell precursors. This response could contribute to the accumulation of mast cells at sites of infection.
53. Prodeus A.P., Zhou X., Maurer M., Galli S.J., and Carroll M.C. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390 (1997) 172-175
54. Nilsson G., Johnell M., Hammer C.H., Tiffany H.L., Nilsson K., Metcalfe D.D., Siegbahn A., and Murphy P.M. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway. J Immunol 157 (1996) 1693-1698
55. Fujita T. Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2 (2002) 346-353
56. Edelson B.T., Stricker T.P., Li Z., Dickeson S.K., Shepherd V.L., Santoro S.A., and Zutter M.M. Novel collectin/C1q receptor mediates mast cell activation and innate immunity. Blood 107 (2006) 143-150. This article demonstrates an important role for the α2/β1 integrin as a receptor for C1q on mast cells. The function of this receptor can be crucial for mast cell mediated host responses to infection.
57. Edelson B.T., Li Z., Pappan L.K., and Zutter M.M. Mast cell-mediated inflammatory responses require the α2β1 integrin. Blood 103 (2004) 2214-2220
58. Ali H., Ahamed J., Hernandez-Munain C., Baron J.L., Krangel M.S., and Patel D.D. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT. J Immunol 165 (2000) 7215-7223
59. Ahamed J., Venkatesha R.T., Thangam E.B., and Ali H. C3a enhances nerve growth factor-induced NFAT activation and chemokine production in a human mast cell line, HMC-1. J Immunol 172 (2004) 6961-6968
60. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl J., Burger R., Guhl S., Haase I., Lippert U., and Zuberbier T. C3a and C5a stimulate chemotaxis of human mast cells. Blood 89 (1997) 2863-2870
61. Venkatesha R.T., Berla Thangam E., Zaidi A.K., and Ali H. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase. Mol Immunol 42 (2005) 581-587
62. Woolhiser M.R., Brockow K., and Metcalfe D.D. Activation of human mast cells by aggregated IgG through FcγRI: additive effects of C3a. Clin Immunol 110 (2004) 172-180
63. Andrasfalvy M., Peterfy H., Toth G., Matko J., Abramson J., Kerekes K., Vamosi G., Pecht I., and Erdei A. The β subunit of the type I Fcε receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells. J Immunol 175 (2005) 2801-2806
64. Erdei A., Andrasfalvy M., Peterfy H., Toth G., and Pecht I. Regulation of mast cell activation by complement-derived peptides. Immunol Lett 92 (2004) 39-42
65. Thangam E.B., Venkatesha R.T., Zaidi A.K., Jordan-Sciutto K.L., Goncharov D.A., Krymskaya V.P., Amrani Y., Panettieri Jr. R.A., and Ali H. Airway smooth muscle cells enhance C3a-induced mast cell degranulation following cell-cell contact. FASEB J 19 (2005) 798-800
66. Kulka M., Alexopoulou L., Flavell R.A., and Metcalfe D.D. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 114 (2004) 174-182
67. McCurdy J.D., Olynych T.J., Maher L.H., and Marshall J.S. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170 (2003) 1625-1629
68. Lin T.J., Maher L.H., Gomi K., McCurdy J.D., Garduno R., and Marshall J.S. Selective early production of CCL20, or macrophage inflammatory protein 3α, by human mast cells in response to Pseudomonas aeruginosa. Infect Immun 71 (2003) 365-373
69. Olynych T., Jakeman D., and Marshall J.S. Dectin-1 mediated leukotriene production from human mast cells. J Allergy Clin Immunol 118 (2006) 837-843. This article demonstrates the crucial role of the co-receptor dectin-1 in mediating the LTC4 response to fungal zymosan activation of human mast cells. This might have important implications for the mast cell response to Aspergillus sp., which is also known to utilize the dectin-1 receptor.
70. Shimada Y., Hasegawa M., Kaburagi Y., Hamaguchi Y., Komura K., Saito E., Takehara K., Steeber D.A., Tedder T.F., and Sato S. L-selectin or ICAM-1 deficiency reduces an immediate-type hypersensitivity response by preventing mast cell recruitment in repeated elicitation of contact hypersensitivity. J Immunol 170 (2003) 4325-4334
71. Okamoto A., Kawamura T., Kanbe K., Kanamaru Y., Ogawa H., Okumura K., and Nakao A. Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-β. Int Immunol 17 (2005) 705-712
72. Kanamaru Y., Sumiyoshi K., Ushio H., Ogawa H., Okumura K., and Nakao A. Smad3 deficiency in mast cells provides efficient host protection against acute septic peritonitis. J Immunol 174 (2005) 4193-4197
73. Gomez G., Ramirez C.D., Rivera J., Patel M., Norozian F., Wright H.V., Kashyap M.V., Barnstein B.O., Fischer-Stenger K., Schwartz L.B., et al. TGF-β1 inhibits mast cell FcεRI expression. J Immunol 174 (2005) 5987-5993
74. Sly L.M., Rauh M.J., Kalesnikoff J., Song C.H., and Krystal G. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21 (2004) 227-239
75. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., Wong S.Y., and Gordon S. Dectin-1 is a major β-glucan receptor on macrophages. J Exp Med 196 (2002) 407-412
76. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197 (2003) 1107-1117
77. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., VanSnick J., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 987-988